Johnson Johnson $ $3.8 billion profit &

Sao Paulo-the giant consumer goods and pharmaceutical Johnson & Johnson recorded consolidated net profits of $ $3.827 billion in the second quarter of 2017, a slight fall in front of the result of the same period last year, to $ $3.997 billion.
The company''s global sales totaled $ $18.839 billion in the second quarter, representing an increase of almost 2% of the revenue of $ $18.482 billion in the same range of 2016. In January to June, revenues reached $ $36.605 billion compared to $ $35.964 billion, up 1.8 percent.
Only in international operations, which include Brazil, revenue totaled $ $9.113 billion, an increase of 2.2% compared to the previous year. The company does not disclose specific results by countries in foreign markets. In the first six months of this year, sales outside the United States totaled $ $17.501 billion, an increase of 2.5% in relation to the performance of the same period last year.
For the year 2017, the company raised your projection for sales growth, which should add up to $ $76.1 billion, down from $ $75.8 billion of the estimate published earlier.
The Administration report, which accompanies the company''s balance sheet, the J&J stood out expect sales growth acceleration in the second half of the year, due to strong demand for new and expensive treatments such as the cancer Darzalex and Imbruvica. Despite this, the company faces strong competition with lower prices for some of its key sectors. And, with almost half of its sales abroad, the company''s results were pressured by a stronger u.s. dollar and weakness in some emerging markets.
While sales of consumer and medical device divisions climbed, in pharmaceutical products-your biggest business-the company showed retraction.
The internal market
In February, in charge of the operation in Latin America of Johnson Johnson, Suzana & Rivetti said during an event in Sao Paulo, the second half of this year is expected to register an acceleration of sales in Brazil, and predicted that the first half of the year would be more difficult for the market of the company.
According to her, however, in General, the scenario for sales in 2017 is more positive compared to last year. In addition, this year, the sales performance will register an improvement in the relationship between prices and volume, said at the time.
The Euromonitor found that, in the category of beauty and personal care, in 2016, Brazil was the world''s sixth largest market J&J, with sales of $ $1.123 billion, to a total of $ $12.2 billion in a consolidated manner in this category. The main markets of the company are North America ($ $4.824 billion), United States ($ $4.520 billion), Asia and the Pacific ($ $2.292 billion) and Western Europe ($ $2.147 billion).
By product category, according to Euromonitor, in 2016, J&J sales in Brazil were pulled by Sun protection items, with a turnover of RS $1.029 billion, followed by children''s products (R $904,000,000) and nozzles (R $898,000,000).
The Brazil is one of the largest global markets on beauty and personal care category. According to the consultancy, R $102.2 billion were moved last year, being R $8.4 billion products nozzles, R $4.8 billions of children''s products and R $3.1 billions of solar protection.